STAT3 and colorectal carcinoma: Moreover, abnormalities in the JAK/STAT pathway are involved in CRC oncogenesis, with aberrant and persistent STAT3 activation being a frequent observation in human CRC that is often associated with poor outcome (Spano et al., 2006; Waldner et al., 2012).